- Previous Close
0.0000 - Open
0.2220 - Bid 0.2220 x 40000
- Ask 0.3498 x 40000
- Day's Range
0.2220 - 0.2220 - 52 Week Range
0.2100 - 5.4900 - Volume
188 - Avg. Volume
38,142 - Market Cap (intraday)
8.438M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0600 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Bio Essence Corporation operates as an herbal health, diet, and nutrition company in the United States. It targets and develops traditional Chinese medicines (TCM) in the form of single herbs, granules, capsules, pills, and tablets; offers special formulation, original equipment manufacturing, and private label services to practitioners and other companies; and manufactures and distributes health supplement products. The company sells its products through TCM practitioners, online websites, brick-and-mortar stores, and other channels. Bio Essence Corporation was incorporated in 2000 and is headquartered in Irvine, California.
www.bioessencecorp.com12
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: BIOE
View MorePerformance Overview: BIOE
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BIOE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BIOE
View MoreValuation Measures
Market Cap
8.44M
Enterprise Value
11.55M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
11.59
Price/Book (mrq)
--
Enterprise Value/Revenue
15.87
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
-0.0600
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--